UniProt ID ▼ | Protein Name | Gene Symbol | No. of Glycosylation Sites | No. of GlyTouCan IDs | Disease Ontology |
---|---|---|---|---|---|
A0A663NAX7 | Hyaluronidase |
|
1 | 0 |
|
A0A663NAM9 | Hyaluronidase |
|
1 | 0 |
|
A0A663NA76 | Hyaluronidase |
|
1 | 0 |
|
A0A663N9Y1 | ADAM metallopeptidase with thrombospondin type 1 motif 1 |
|
2 | 0 |
|
A0A663N8D0 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A663N8A2 | Hyaluronidase |
|
1 | 0 |
|
A0A663N837 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A663N831 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A663N7R5 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A663N7E4 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A663N7C5 | Pannexin |
|
1 | 0 |
|
A0A663N6X2 | Hyaluronidase |
|
1 | 0 |
|
A0A663N6Q4 | ADAM metallopeptidase with thrombospondin type 1 motif 1 |
|
2 | 0 |
|
A0A663N5Z2 | Beta-secretase 2 |
|
1 | 0 |
|
A0A663N5S5 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A663N4L8 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A663N476 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A663N3H4 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A663N3F0 | Voltage-dependent L-type calcium channel subunit alpha-1C |
|
1 | 0 |
|
A0A663MYE1 | Phosphoinositide phospholipase C |
|
1 | 0 |
|
A0A663MXI2 | Fibroblast growth factor receptor |
|
8 | 0 |
|
A0A663MXH6 | Fibroblast growth factor receptor |
|
8 | 0 |
|
A0A663MXE0 | N-acetylgalactosamine-6-sulfatase |
|
2 | 0 |
|
A0A663MW27 | Peptidylglycine alpha-amidating monooxygenase |
|
1 | 0 |
|
A0A663MVT9 | Peptidylglycine alpha-amidating monooxygenase |
|
1 | 0 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024